S
Sabrina R Williams
Researcher at Centers for Disease Control and Prevention
Publications - 9
Citations - 266
Sabrina R Williams is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Incidence (epidemiology). The author has an hindex of 6, co-authored 9 publications receiving 132 citations. Previous affiliations of Sabrina R Williams include Emory University.
Papers
More filters
Journal ArticleDOI
Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016
Mitsuru Toda,Sabrina R Williams,Elizabeth L. Berkow,Monica M. Farley,Lee H. Harrison,Lindsay Bonner,Kaytlynn Marceaux,Rosemary Hollick,Alexia Y Zhang,William Schaffner,Shawn R. Lockhart,Brendan R Jackson,Snigdha Vallabhaneni +12 more
TL;DR: Nearly nine out of 100,000 persons developed culture-positive candidemia annually in four U.S. sites, suggesting that the youngest and oldest persons, men, and blacks had the highest incidences of candidemia.
Journal ArticleDOI
Burden of Candidemia in the United States, 2017
Sharon Tsay,Yi Mu,Sabrina R Williams,Erin Epson,Joelle Nadle,Wendy Bamberg,Devra Barter,Helen Johnston,Monica M. Farley,Monica M. Farley,Sasha Harb,Stepy Thomas,Lindsay Bonner,Lee H. Harrison,Rosemary Hollick,Kaytlynn Marceaux,Rajal K. Mody,Brittany Pattee,Sarah Shrum Davis,Erin C Phipps,Brenda L Tesini,Anita Gellert,Alexia Y Zhang,William Schaffner,Sherry Hillis,Danielle Ndi,Caroline R Graber,Brendan R Jackson,Tom Chiller,Shelley S. Magill,Snigdha Vallabhaneni +30 more
TL;DR: This analysis highlights the substantial burden of candidemia in the U.S. because candidemia is only one form of invasive candidiasis, the true burden of invasive infections due to Candida is higher.
Journal ArticleDOI
The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017
Alexia Y Zhang,Sarah Shrum,Sabrina R Williams,Sarah Petnic,Joelle Nadle,Helen Johnston,Devra Barter,Brittany VonBank,Lindsay Bonner,Rosemary Hollick,Kaytlynn Marceaux,Lee H. Harrison,William Schaffner,Brenda L Tesini,Monica M. Farley,Rebecca Pierce,Erin C Phipps,Rajal K. Mody,Tom Chiller,Brendan R Jackson,Snigdha Vallabhaneni +20 more
TL;DR: Clinicians should consider screening for candidemia in people who inject drugs and IDU in patients with candidemia who lack typical candidemia risk factors, especially in those with who are 19-44 years, and have community-associated candidemia.
Journal ArticleDOI
Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
Jennifer Milucky,Maria de Gloria Carvalho,Nadine Rouphael,Nancy M. Bennett,H. Keipp Talbot,Lee H. Harrison,Monica M. Farley,Monica M. Farley,Jeremy D. Walston,Fabiana Cristina Pimenta,Fernanda C. Lessa,Mary Bower,Nina N. McNair,Nina N. McNair,Sabrina R Williams,Emily Presmanes,Amy Tunali,Stephanie Thomas,Rosemary Hollick,Jacqueline M. Langdon,Amir Salar Sepehri,Anna Sharova +21 more
TL;DR: Pneumococcal carriage among non-institutionalized adults ≥65 years of age was very low, and given the low vaccine-type carriage rates observed in an already high PCV13 adult coverage setting, it is difficult to attribute the findings to the direct versus indirect effects ofPCV13 on adult carriage.
Journal ArticleDOI
363. National Burden of Candidemia, United States, 2017
Sharon Tsay,Sabrina R Williams,Yi Mu,Erin Epson,Helen Johnston,Monica M. Farley,Lee H. Harrison,Brittany VonBank,Sarah Shrum,Ghinwa Dumyati,Alexia Zhang,William Schaffner,Shelley S. Magill,Snigdha Vallabhaneni +13 more
TL;DR: The analysis highlights the substantial burden of candidemia in the US because candidemia is only one form of invasive candidiasis, the true burden of invasive infections due to Candida species is likely higher.